SJL dystrophic mice express a significant amount of human muscle proteins following systemic delivery of human adipose-derived stromal cells without immunosuppression.
about
Human stem cell cultures from cleft lip/palate patients show enrichment of transcripts involved in extracellular matrix modeling by comparison to controlsPotential of adipose-derived stem cells in muscular regenerative therapiesBone marrow transplantation in dysferlin-deficient mice results in a mild functional improvement.Enhancement of myogenic and muscle repair capacities of human adipose-derived stem cells with forced expression of MyoD.Human adipose-derived stem cell transplantation as a potential therapy for collagen VI-related congenital muscular dystrophyNovel diagnostic features of dysferlinopathies.Preclinical studies with umbilical cord mesenchymal stromal cells in different animal models for muscular dystrophy.Impact of leucine supplementation on exercise training induced anti-cardiac remodeling effect in heart failure mice.Lack of β2 -adrenoceptors aggravates heart failure-induced skeletal muscle myopathy in mice1α,25(OH)(2)-Vitamin D3 increases dysferlin expression in vitro and in a human clinical trial.Dose and latency effects of leucine supplementation in modulating glucose homeostasis: opposite effects in healthy and glucocorticoid-induced insulin-resistance states.Neuromuscular disorders: genes, genetic counseling and therapeutic trialsHuman fallopian tube: a new source of multipotent adult mesenchymal stem cells discarded in surgical procedures.A new method for treating fecal incontinence by implanting stem cells derived from human adipose tissue: preliminary findings of a randomized double-blind clinical trialAdipose-derived mesenchymal stem cells and regenerative medicine.Cellular kinetics of perivascular MSC precursors.Concise review: mesoangioblast and mesenchymal stem cell therapy for muscular dystrophy: progress, challenges, and future directions.Applicability of adipose-derived stem cells in type 1 diabetes mellitus.Human adipose-derived mesenchymal stromal cells injected systemically into GRMD dogs without immunosuppression are able to reach the host muscle and express human dystrophin.Myogenic differentiation of mesenchymal stem cells co-cultured with primary myoblasts.Platelet-rich plasma favors proliferation of canine adipose-derived mesenchymal stem cells in methacrylate-endcapped caprolactone porous scaffold niches.Gene expression profile of mesenchymal stem cells from paired umbilical cord units: cord is different from blood.Aerobic exercise training improves skeletal muscle function and Ca2+ handling-related protein expression in sympathetic hyperactivity-induced heart failure.Systemic delivery of human mesenchymal stromal cells combined with IGF-1 enhances muscle functional recovery in LAMA2 dy/2j dystrophic mice.Isolation, characterization, and differentiation potential of canine adipose-derived stem cells.Transplantation of Human Adipose Mesenchymal Stem Cells in Non-Immunosuppressed GRMD Dogs is a Safe Procedure.Human insulin secreted from insulinogenic xenograft restores normoglycemia in type 1 diabetic mice without immunosuppression.Evaluation of different commercial hyaluronic acids as a vehicle for injection of human adipose-derived mesenchymal stem cellsAdipose-Derived Stem Cells in Tissue Regeneration: A ReviewTranslational Research in Stem Cell Treatment of Neuromuscular Diseases
P2860
Q24622117-6A3B5C1F-41A4-474E-A27E-A841D4B8ECAEQ26798810-F92C70EA-A2A0-46FF-A0DC-6A7090028A4EQ30552419-98FDAAE6-3100-4C2E-8F17-77D769FC20FBQ33713683-52331CB6-15AC-4996-B7C5-F270449842E0Q33745931-2E8B8F78-83E9-4587-9D51-23B403FDD33FQ34513720-B3B7990E-C26F-4E3B-B5EB-4406AB69717DQ35113901-6D2AA904-8F6D-429C-9F98-E794C5F99E14Q35658207-D7AB83A9-CE78-4D95-B08B-EFA1BCF15F3FQ35867936-12DF89EF-09AE-4C7E-A9ED-C44CAF539030Q36298643-5D8F4D1A-32D5-4410-8CCF-A6026F2586CFQ36538118-96DF4F19-8A20-40E8-8516-859BE45700A9Q37217303-399B579B-A6D2-4734-8E73-6822A231E94BQ37270545-172DA479-368D-4CB6-A39C-F409D4494C4BQ37658490-4963EA82-C5A9-4967-A767-FD5BB35DACBCQ38085695-001EAC50-D41B-428E-88CB-3BD2D4D3504EQ38136188-A32D3442-D13F-4F56-82B9-6EE3271421F2Q38267714-77607534-E914-49E3-A5BB-D5696E6934E4Q38332629-B08BFFA6-9951-4A3A-A8F4-F5D27B767AD6Q39516901-3925B0A7-FCBC-48EB-ADE7-2A4F3409BDD6Q39644238-A0322305-4FBE-4E71-8D1F-C1B175161379Q39872644-9C117F11-D5B2-4AC5-8BAC-E1C50BE0783AQ39911508-ED137B62-88DC-4752-962B-8937D2EEB8AEQ42994275-D6875256-9E44-40B3-BA96-89660B551818Q44949025-A230392E-4B81-427B-849E-3257EBF7F597Q48392304-49A51F75-58F3-4FC9-90C8-D0E8C7500755Q53097033-4536A95F-8742-46C9-86FC-CB078AD8594AQ53381073-7E0938A3-5388-405F-B61E-124C8CBCFF81Q57171240-21BB5B99-0FC9-4F6E-980D-082CABD8AD55Q58999088-8F5A99F4-4CE7-46FB-914F-1D2D8052B276Q59001351-DA6A6AF7-1EA2-499A-B23C-D660F05630FF
P2860
SJL dystrophic mice express a significant amount of human muscle proteins following systemic delivery of human adipose-derived stromal cells without immunosuppression.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
SJL dystrophic mice express a ...... lls without immunosuppression.
@en
type
label
SJL dystrophic mice express a ...... lls without immunosuppression.
@en
prefLabel
SJL dystrophic mice express a ...... lls without immunosuppression.
@en
P2093
P50
P1433
P1476
SJL dystrophic mice express a ...... lls without immunosuppression.
@en
P2093
Carlos R Bueno
Luciana V Moraes
Mariane Secco
Maristela M Camargo
Natássia M Vieira
Paolo Bartolini
Patricia C Brum
Vanessa Brandalise
P304
P356
10.1634/STEMCELLS.2008-0043
P577
2008-06-26T00:00:00Z